Date
Topic
Speaker
6/23/25
Registration/Breakfast
Welcome
Alejandro Sweet-Cordero, MD
Arun Rangaswami, MD
UCSF Benioff Children’s Hospitals
Keynote
James Feusner,
UCSF Benioff Children’s Hospitals
Trial/Pilot Study Status
Alli O’Neill, MD
Dana Farber Cancer Institute
Tomoro Hishiki, MD, PhD
Chiba University Hospital
Sophie Brancheaureau, MD
Georges Pompidou European Hospital
Paediatric Hepatic International Tumour Trial (PHITT)
Greg Tiao, MD
Cincinnati Children's Hospital
Eiso Hiyama, MD, PhD
Hiroshima University
Madhumita Dandapani, MBBS, MRCPCH, PhD
University of Nottingham
European High Risk EXPLORER Pilot (SIOPEL)
Jozsef Zsiros,
Princess Máxima Center (The Netherlands)
High Risk Pilot (COG/JCCG)
Angela Trobaugh-Lotrario, MD
Sacred Heart Medical Center - Providence
Coffee Break
Hepatocellular Neoplasms Biology & Pathology:
-Biomarker Consensus Analysis and Discussion of Future Application in PHITT2
Lola Lopez-Terrada, MD, PhD
Texas Children's Hospital
Eiso Hiyama, MD, PhD
Hiroshima University
Carolina Armengol Niell, PhD
Germans Trias i Pujol Research
Development Biology/Pathophysiology: Status and Future
Lola Lopez-Terrada, MD, PhD
Texas Children's Hospital
Amar Nijagal, MD
UCSF Benioff Children’s Hospitals
Rob Schwartz, MD, PhD
New York Presbyterian Hospital Cornell
Bruce Wang, MD
UCSF Health
Lunch
Biology, Epidemiology, Pathology:
-Biology (HB/HCN NOS)
Pavel Sumazin, PhD
Texas Children’s Hospital
Genta Nagae, PhD
University of Tokyo
Roland Kappler
Ludwig-Maximilians-Universität in Munich
Thomas Kluiver
Princess Máxima Center for Pediatric Oncology
-Biology (HCC)
-Pathology
-Epidemiology
Theo Hirsch, PhD
Cordeliers Research Center
Genta Nagae, PhD
University of Tokyo
Soo-Jin Cho, MD
UCSF Benioff Children’s Hospitals
Hiroko Fukushima, MD, PhD
Osaka City Juso Hospital (Japan)
Juan Putra, MD
Boston Children’s Hospital
Logan Spector
University of Minnesota
Erin Marcotte, PhD
University of Minnesota
HCC: Biology/Mechanisms of Resistance
Eiso Hiyama, MD, PhD
Hiroshima University
Tim Greten, MD
National Cancer Institute
Kate Somers, MD
Cincinnati Children’s Hospital Medical Center
Sarah Woodfield, PhD
Baylor College of Medicine
Genta Nagae, PhD
University of Tokyo
FLC (JHU Vaccine Trial, FLC Pilot)
Sandy Simon, PhD
The Rockefeller University
Michael Ortiz, MD
Memorial Sloan Kettering Cancer Center
John Gordon, MD, PhD
UCSF Health
Marina Baretti, MD
Johns Hopkins Medicine
Michael Ortiz, MD
Memorial Sloan Kettering Cancer Center
Welcome Reception
Dinner
Date
Topic
Speaker
6/24/25
Registration/Breakfast
Liver “Omics” – Biology, Radionomics, ctDNA: Advances in Diagnostic Methods and Disease Monitoring
Genta Nagae, PhD
University of Tokyo
Genta Nagae, PhD
Cincinnati Children’s Hospital
Eiso Hiyama, MD, PhD
Hiroshima University
Nensi Ruzgar, MD
Dana-Farber Cancer Institute
ICG
Sanjeev Vasudevan
Texas Children’s Hospital
Tomoro Hishiki, MD, PhD
Chiba University Hospital
Sophie Brancheauraeu, MD
Georges Pompidou European Hospital
Advances in Local Control (Surgical/IR)
- Characterizing appropriate candidacy for extreme resection vs transplant, results of AHEP0731 imaging reviews
- Extreme Resection
- Resection v. Transplant
- Should salvage transplant be offered for all unresectable relapse confined to liver?
- 3D modeling to enhance preop respectability for malignant liver tumors
- Applying adult IR techniques and approaches to pediatric liver tumors (Gill)- can discuss histotripsy
- Guided surgery, benefits and pitfalls
Sanjeev Vasudevan
Texas Children’s Hospital
Greg Tiao, MD
Cincinnati Children’s Hospital
Sophie Brancheauraeu, MD
Georges Pompidou European Hospital
Sang-Mo Kang, MD
UCSF Benioff Children’s Hospitals
Eiso Hiyama, MD, PhD
Hiroshima University
Anne Gill, MD
Children’s Healthcare of Atlanta
Hepatocellular Neoplasms: Resistance Mechanisms
Tomoro Hishiki, MD, PhD
Chiba University Hospital
Jim Gellar, MD
Cincinnati Children’s Hospital Medical Center
Genta Nagae, PhD
University of Tokyo
Sarah Woodfield, PhD
Baylor College of Medicine
UESL
Aaron Weiss, DO
Maine Health
Zachary Kastenberg, MD, MS
University of Utah School of Medicine
Prachi Kothari, DO
The Children’s Hospital of Philadelphia
Hiroko Fukushima, MD, PhD
Osaka City Juso Hospital (Japan)
Jessica Gartell, MD
St. Jude Children’s Research Hospital
Immunosuppression/Transplant
Emily Perito, MD, MAS
UCSF Benioff Children’s Hospitals
Greg Tiao, MD
Cincinnati Children’s Hospital
Yohei Yamada, MD
Keio University
Sophie Brancheauraeu, MD
Georges Pompidou European Hospital
Sue Rhee, MD
UCSF Benioff Children’s Hospitals
Heung-Bae Kim, MD
Boston Children’s Hospital
Sang-Mo Kang, MD
UCSF Benioff Children’s Hospitals
Epidemiology/Predispositions/Survivorship
Arun Rangaswami, MD
UCSF Benioff Children’s Hospitals
Logan Spector
University of Minnesota
Erin Marcotte, PhD
University of Minnesota
Disparities
Kira Bona, MD, MPH
Boston Children’s Hospital
Rahela Aziz-Bose, MD
Boston Children’s Hospital
Lena Winestone, MD, MS
UCSF Benioff Children’s Hospitals
Rahela Aziz-Bose, MD
Dana Farber Cancer Institute
Kira Bona, MD, MPH
Dana Farber Cancer Institute
Date
Topic
Speaker
6/25/25
Registration/Breakfast
Patient/Family Forum
The Hepatoblastoma Resource Network
CHIC: Pathology, Low AFP Tumors, AFP Decline, CHIC Validation, PCDC Migration: Radiology, Surgery, Oncology, Annotation Factor Analysis
Häberle, MD
Ludwig Maximilian University of Munich (Germany)
Eiso Hiyama, MD, PhD
Hiroshima University
Arun Rangaswami, MD
UCSF Benioff Children’s Hospitals
Soo-Jin Cho, MD
UCSF Benioff Children’s Hospitals
Angela Trobaugh-Lotario, MD
Sacred Heart Medical Center – Providence
Alli O’Neill, MD
Dana-Farber Cancer Institute
Alex Towbin, MD>
Cincinnati Children’s Hospital
Greg Tiao, MD
Cincinnati Children’s Hospital
Kim Riehle, MD
Seattle Children’s
Relapse/Registries: Relapse Strategies, RELIVE, PSORC, LTR
Marc Ansari, MD
University of Geneva
Jim Gellar, MD
Cincinnati Children’s Hospital Medical Center
Alli O’Neill, MD
Dana-Farber Cancer Institute
Angela Trobaugh-Lotario, MD
Sacred Heart Medical Center – Providence
Rudolf Maibach, PhD
ETOP IBCSG Partners Foundation
(Switzerland)
Roshni Dasgupta, MD, MPH
Cincinnati Children’s Hospital Medical Center
Eiso Hiyama, MD, PhD
Hiroshima University
Kenichiro Watanabe, PhD
Nippon Medical School
Cutting Edge Advances in Therapies/Novel Therapeutics
Alli O’Neill, MD
Dana-Farber Cancer Institute
Irene Schmid, MD
Dr. Von Hauner Children’s Hospital
Sanjeev Vasudevan
Texas Children’s Hospital
Andras Heczey, MD
Texas Children’s Hospital
Richard Finn, MD
UCLA Health
Summary
Closing Remarks
Marcio Henrique Malogolowkin, MD
University of California – Davis Health
Arun Rangaswami, MD
UCSF Benioff Children’s Hospitals
